Table 2 Baseline postoperative morbidity and medication characteristics of 261 patients underwent a Fontan completion
From: Impact of older age at Fontan completion on mid-term survival
Postoperative morbidity | Age ≤ 6 years (n = 139) | Age > 6 years (n = 122) | p value |
|---|---|---|---|
Thromboembolism | 8 (5.8%) | 9 (7.4%) | 0.597 |
PLE | 0 (0%) | 8 (6.6%) | 0.002* |
Pleura effusion | 68 (48.9%) | 62 (50.8%) | 0.760 |
Postoperative arrhythmia | 40 (28.6%) | 30 (24.6%) | 0.447 |
Infection | 35 (25.2%) | 27 (22.1%) | 0.815 |
Heart failure | 3 (2.2%) | 9 (7.4%) | 0.045* |
Bleeding | 18 (12.9%) | 13 (10.7%) | 0.568 |
Rehospitalization | 38 (27.3%) | 33 (27%) | 0.958 |
Medication** | |||
ACE inhibitor | 113 (81.3%) | 90 (73.8%) | 0.145 |
Sildenafil | 56 (40.3%) | 45 (36.9%) | 0.574 |
Furosemide | 26 (18.7%) | 16 (13.1%) | 0.221 |
Antiplatelet | 9 (6.5%) | 10 (8.2%) | 0.594 |
Anticoagulant | 126 (90.6%) | 102 (83.6%) | 0.088 |
Beta blocker | 19 (13.7%) | 15 (12.3%) | 0.743 |